Cargando…
Asprosin—A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature
Asprosin is a recently discovered protein released during fasting conditions mainly by adipocytes from white adipose tissue. As a glucogenic peptide, it stimulates the release of glucose from hepatic cells by binding to the OLFR734 receptor and leading to the activation of the G protein-cAMP-PKA pat...
Autor principal: | Mazur-Bialy, Agnieszka Irena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918151/ https://www.ncbi.nlm.nih.gov/pubmed/33673009 http://dx.doi.org/10.3390/nu13020620 |
Ejemplares similares
-
Asprosin is a centrally-acting orexigenic hormone
por: Duerrschmid, Clemens, et al.
Publicado: (2017) -
Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer
por: Kerslake, Rachel, et al.
Publicado: (2022) -
Gonacin: A germ cell-derived hormone with glucogenic, orexigenic, and gonadal activities
por: Hu, Yixuan, et al.
Publicado: (2023) -
OR23-3 Hunger Hormone Asprosin Activates Orexigenic Neurons via SK Currents
por: Feng, Bing, et al.
Publicado: (2022) -
Asprosin Enhances Cytokine Production by a Co-Culture of Fully Differentiated Mature Adipocytes and Macrophages Leading to the Exacerbation of the Condition Typical of Obesity-Related Inflammation
por: Mazur-Bialy, Agnieszka I.
Publicado: (2023)